Martin Steinau

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. pmc Performance of commercial reverse line blot assays for human papillomavirus genotyping
    Martin Steinau
    WHO Human Papillomavirus Laboratory Network Global Reference Laboratory, Chronic Viral Diseases Branch, Division of High Consequence Pathogens, and National Center for Emerging and Zoonotic Infectious Diseases Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Clin Microbiol 50:1539-44. 2012
  2. pmc Gene expression profile of cervical tissue compared to exfoliated cells: impact on biomarker discovery
    Martin Steinau
    Centers for Disease Control and Prevention, Atlanta, GA, USA
    BMC Genomics 6:64. 2005
  3. ncbi request reprint Evaluation of RNA markers for early detection of cervical neoplasia in exfoliated cervical cells
    Martin Steinau
    Division of Viral and Rickettsial Disease, Viral Exanthems and Herpesvirus Branch, Centers for Disease Control and Prevention, 1600 Clifton Road, MS G 41, Atlanta, GA 30333, USA
    Cancer Epidemiol Biomarkers Prev 16:295-301. 2007
  4. doi request reprint Type-specific reproducibility of the Roche linear array HPV genotyping test
    Martin Steinau
    Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector Borne and Enteric Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Clin Virol 42:412-4. 2008
  5. pmc Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues
    Martin Steinau
    Chronic Viral Diseases Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Mol Diagn 13:377-81. 2011
  6. doi request reprint Human papillomavirus genotypes in high-grade cervical lesions in the United States
    Susan Hariri
    Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 206:1878-86. 2012
  7. pmc Age-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopy
    Julia W Gargano
    Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, MS C09, 1600 Clifton Rd NE, Atlanta, GA 30333, USA
    Cancer Epidemiol Biomarkers Prev 21:111-21. 2012
  8. doi request reprint Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010
    Lauri E Markowitz
    National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Infect Dis 208:385-93. 2013
  9. doi request reprint Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction
    Julia W Gargano
    Epidemic Intelligence Service, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Low Genit Tract Dis 16:471-9. 2012
  10. doi request reprint Impact of HPV assay on observed population prevalence
    Elizabeth R Unger
    Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic, Infectious Diseases proposed, Chronic Viral Diseases Branch Atlanta, GA, USA
    Diagn Mol Pathol 20:101-4. 2011

Collaborators

Detail Information

Publications22

  1. pmc Performance of commercial reverse line blot assays for human papillomavirus genotyping
    Martin Steinau
    WHO Human Papillomavirus Laboratory Network Global Reference Laboratory, Chronic Viral Diseases Branch, Division of High Consequence Pathogens, and National Center for Emerging and Zoonotic Infectious Diseases Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Clin Microbiol 50:1539-44. 2012
    ..942), respectively. Although the assays had good concordance in the clinical samples, the greater accuracy and specificity in the plasmid panel suggest that LA has an advantage for internationally comparable genotyping studies...
  2. pmc Gene expression profile of cervical tissue compared to exfoliated cells: impact on biomarker discovery
    Martin Steinau
    Centers for Disease Control and Prevention, Atlanta, GA, USA
    BMC Genomics 6:64. 2005
    ..However, because of keratinization and terminal differentiation it is not clear that these cells have an mRNA profile representative of cervical tissue, and that the profile can distinguish the lesions targeted for early detection...
  3. ncbi request reprint Evaluation of RNA markers for early detection of cervical neoplasia in exfoliated cervical cells
    Martin Steinau
    Division of Viral and Rickettsial Disease, Viral Exanthems and Herpesvirus Branch, Centers for Disease Control and Prevention, 1600 Clifton Road, MS G 41, Atlanta, GA 30333, USA
    Cancer Epidemiol Biomarkers Prev 16:295-301. 2007
    ....
  4. doi request reprint Type-specific reproducibility of the Roche linear array HPV genotyping test
    Martin Steinau
    Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector Borne and Enteric Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Clin Virol 42:412-4. 2008
    ..Inter-assay comparability studies have been performed, but the robustness of type-specific results has neither been emphasized nor has the degree of intra-assay reproducibility been addressed...
  5. pmc Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues
    Martin Steinau
    Chronic Viral Diseases Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Mol Diagn 13:377-81. 2011
    ..035). Aggressive heat treatment demonstrated an advantage over traditional xylene purification protocols, resulting in higher DNA yields and increased sensitivity for HPV testing...
  6. doi request reprint Human papillomavirus genotypes in high-grade cervical lesions in the United States
    Susan Hariri
    Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 206:1878-86. 2012
    ..Monitoring HPV types in CIN2+ may be used to assess HPV vaccine impact...
  7. pmc Age-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopy
    Julia W Gargano
    Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, MS C09, 1600 Clifton Rd NE, Atlanta, GA 30333, USA
    Cancer Epidemiol Biomarkers Prev 21:111-21. 2012
    ..Here, we assess age-group differences in HPV types and other risk factors for cervical intraepithelial neoplasia (CIN) grade 3 or worse (CIN3+) versus CIN0-2 in women from four colposcopy clinics...
  8. doi request reprint Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010
    Lauri E Markowitz
    National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Infect Dis 208:385-93. 2013
    ..In 2010, 3-dose vaccine coverage was only 32% among 13-17 year-olds. Reduction in the prevalence of HPV types targeted by the quadrivalent vaccine (HPV-6, -11, -16, and -18) will be one of the first measures of vaccine impact...
  9. doi request reprint Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction
    Julia W Gargano
    Epidemic Intelligence Service, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Low Genit Tract Dis 16:471-9. 2012
    ..The study aimed to determine the baseline prevalence of human papillomavirus (HPV) types in invasive vulvar cancer (IVC) and vulvar intraepithelial neoplasia 3 (VIN 3) cases using data from 7 US cancer registries...
  10. doi request reprint Impact of HPV assay on observed population prevalence
    Elizabeth R Unger
    Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic, Infectious Diseases proposed, Chronic Viral Diseases Branch Atlanta, GA, USA
    Diagn Mol Pathol 20:101-4. 2011
    ..Studies designed to examine temporal trends in type-specific prevalence should archive residual material to permit retesting if assays change...
  11. pmc HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006
    Susan Hariri
    Division of STD Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 7:e34044. 2012
    ..This study aimed to evaluate 2 commercial assays for HPV detection and typing using FFPE cervical specimens...
  12. ncbi request reprint Molecular markers for early detection of cervical neoplasia
    Elizabeth R Unger
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, GA 30333, USA
    Dis Markers 20:103-16. 2004
  13. doi request reprint Differences and changes in human papillomavirus type 16 variant status in human immunodeficiency virus-positive adults are not uncommon
    Martin Steinau
    Centers for Disease Control and Prevention, National Center for Zoonotic, Vector Borne and Enteric Diseases, Chronic Viral Diseases Branch Atlanta, GA 30333, USA
    J Gen Virol 91:2068-72. 2010
    ..6%) instances (seven anal and two cervical) from eight different participants. Changes in HPV-16 variants in HIV-infected adults were seen most frequently when different anatomical sites were sampled, but were also observed over time...
  14. doi request reprint Oral sampling and human papillomavirus genotyping in HIV-infected patients
    Martin Steinau
    Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, USA
    J Oral Pathol Med 41:288-91. 2012
    ..Screening may be useful, but methodologies and results have varied widely in previous studies. We conducted a pilot study in an HIV-positive population to evaluate HPV detection in four different oral sample types...
  15. ncbi request reprint A real-time PCR assay for HPV52 detection and viral load quantification
    Juanita M Onyekwuluje
    Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of High Consequence Pathogens and Pathology, Chronic Viral Diseases Branch, Atlanta, GA 30333, USA
    Clin Lab 58:61-6. 2012
    ....
  16. ncbi request reprint Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome
    Martin Steinau
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, MSG 41, Atlanta, GA 30333, USA
    J Mol Med (Berl) 82:750-5. 2004
    ..The real-time reverse-transcription PCR assays that we developed for assay of these biomarkers will facilitate high-throughput testing of these additional samples...
  17. doi request reprint RNA profiling in peripheral blood cells by fluorescent differential display PCR
    Martin Steinau
    National Center for Zoonotic, Vector Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Methods Mol Biol 496:211-22. 2009
    ..Besides the DD-PCR itself, methods are described for subsequent extraction, amplification, and sequencing of DNA from bands of interest to identify the corresponding genes...
  18. doi request reprint Can clinical tests help monitor human papillomavirus vaccine impact?
    Elissa Meites
    Division of STD Prevention, National Center for HIV AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA
    Int J Cancer 133:1101-6. 2013
    ..Further investigation is warranted to inform type-specific HPV monitoring approaches around the world. ..
  19. doi request reprint Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions
    Suzanne E Powell
    Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, NE MS E02, Atlanta, GA 30333, USA
    Vaccine 31:109-13. 2012
    ..This report describes vaccination status in women diagnosed with CIN2+ and examines HPV vaccine impact on HPV 16/18-related CIN2+...
  20. pmc DNA and RNA references for qRT-PCR assays in exfoliated cervical cells
    Martin Steinau
    Human Papillomavirus Program, Centers for Disease Control and Prevention, 1600 Clifton Rd, MS G41, Atlanta, GA 30333, USA
    J Mol Diagn 8:113-8. 2006
    ..These genes also showed the highest correlation with DNA contents in the same samples. If special attention to intraepithelial lesions is appropriate, RPL4 and PGK1 are recommended as the best combination of two genes...
  21. doi request reprint Prevalence of HPV types in cervical specimens from an integrated healthcare delivery system: baseline assessment to measure HPV vaccine impact
    Eileen F Dunne
    Division of STD Prevention, Centers for Disease Control and Prevention CDC, Atlanta, GA 30333, USA
    Cancer Causes Control 24:403-7. 2013
    ..We aimed to assess feasibility of specimen collection and baseline HPV prevalence in an integrated healthcare delivery system...
  22. ncbi request reprint Aberrant mRNA processing of the maize Rp1-D rust resistance gene in wheat and barley
    Michael A Ayliffe
    CSIRO Plant Industry, Box 1600, Canberra, ACT, 2601, Australia
    Mol Plant Microbe Interact 17:853-64. 2004
    ....